Quantitative Evaluation of Artificial Intelligence-Based Organ Segmentation Across Multiple Anatomic Sites Using 8 Commercial Software Platforms
Practical Radiation Oncology · 2026
DOI: 10.1016/j.prro.2025.06.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Practical Radiation Oncology, 2026. Verfasst von Lulin Yuan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia. Electronic address: lulin.yuan@vcuhealth.org. Hauptthemen laut MEDLINE: Software, Artificial Intelligence, Organs at Risk, Radiotherapy Planning, Computer-Assisted. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NRG Oncology.
Abstract (Originalsprache)
PURPOSE: This study aims to evaluate organs-at-risk (OARs) segmentation variability across 8 commercial artificial intelligence (AI)-based segmentation software using independent multi-institutional data sets, and to provide recommendations for clinical practices using AI-segmentation. METHODS AND MATERIALS: A total of 160 planning computed tomography image sets from 4 anatomic sites: head and neck, thorax, abdomen, and pelvis were retrospectively pooled from 3 institutions. Contours for 31 OARs generated by the software were compared to clinical contours using multiple accuracy metrics, including: dice similarity coefficient (DSC), 95 percentile of Hausdorff distance, surface DSC, as well as relative added path length as an efficiency metric. A 2-factor analysis of variance was used to quantify variability in contouring accuracy across software platforms (intersoftware) and patients (interpatient). Pairwise comparisons were performed to categorize the software into different performance groups, and intersoftware variations were calculated as the average performance differences between the groups. RESULTS: Significant intersoftware and interpatient contouring accuracy variations (P 0.9 (ie, heart, liver), 15 had DSC ranging from 0.7 to 0.89 (ie, parotid, esophagus). The remaining organs (ie, optic nerves, seminal vesicle) had DSC
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia. Electronic address: lulin.yuan@vcuhealth.org.
- Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, Duarte, California; Department of Radiation Oncology, Mayo Clinic Arizona, Phoenix, Arizona.
- Department of Radiation Oncology, Emory University, Atlanta, Georgia.
- Radiation Physics, MD Anderson Cancer Center, Houston, Texas.
- Department of Radiation Oncology, University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania.
- Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida.
Förderung
- NCI NIH HHS
- NRG Oncology
Zitieren
APA
Yuan, L., Chen, Q., Al-Hallaq, H., Yang, J., Yang, X., Geng, H., Latifi, K., Cai, B., Wu, Q. J., Xiao, Y., Benedict, S. H., Rong, Y., Buchsbaum, J., & Qi, X. S. (2026). Quantitative Evaluation of Artificial Intelligence-Based Organ Segmentation Across Multiple Anatomic Sites Using 8 Commercial Software Platforms. Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2025.06.012
Vancouver
Yuan L, Chen Q, Al-Hallaq H, Yang J, Yang X, Geng H, et al. Quantitative Evaluation of Artificial Intelligence-Based Organ Segmentation Across Multiple Anatomic Sites Using 8 Commercial Software Platforms. Practical Radiation Oncology. 2026. doi:10.1016/j.prro.2025.06.012
BibTeX
@article{Yuan2026,
author = {Yuan, Lulin and Chen, Quan and Al-Hallaq, Hania and Yang, Jinzhong and Yang, Xiaofeng and Geng, Huaizhi and Latifi, Kujtim and Cai, Bin and Wu, Qingrong Jackie and Xiao, Ying and Benedict, Stanley H and Rong, Yi and Buchsbaum, Jeff and Qi, X Sharon},
title = {Quantitative Evaluation of Artificial Intelligence-Based Organ Segmentation Across Multiple Anatomic Sites Using 8 Commercial Software Platforms},
journal = {Practical Radiation Oncology},
year = {2026},
doi = {10.1016/j.prro.2025.06.012}
}
EUVIMED